PD6-08 HOSPITAL READMISSIONS AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY IN THE VA MEDICAL SYSTEM

Abstract

You have accessJournal of UrologyProstate Cancer: Epidemiology & Natural History II1 Apr 2015PD6-08 HOSPITAL READMISSIONS AFTER TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY IN THE VA MEDICAL SYSTEM Mark Garzotto, James Edwards, and Michael Conlin Mark GarzottoMark Garzotto More articles by this author , James EdwardsJames Edwards More articles by this author , and Michael ConlinMichael Conlin More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2015.02.803AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Emerging data have shown that prostate biopsy infections occur commonly after routine prostate biopsy procedures. Data from a recent Medicare based sample showed hospitalization to occur at a rate of 6.9% (J Urol 186:1830). The primary endpoint of this study was to determine the risk of hospital admission after a prostate biopsy in the Veterans Health Administration (VA) system. Secondary endpoints include determination of risk factors associated with higher risk of hospitalization. METHODS We performed a data query from the VA Corporate Data Warehouse (CDW) for all prostate biopsies performed in the VA nationally over an 11-year period from 2003 to 2013. Data extracted included age, race, data of procedure, and relevant laboratory data. Information on 30-day rate-of-hospitalization, reason for admission, and other inpatient related data were collected. Multivariable logistic regression was used to examine the risk factors associated with readmission RESULTS There were 310,334 prostate biopsies performed in the VA between 2003 and 2013. The average number of biopsies per year over this time period was 28,212. The number of biopsies per year remained steady throughout the study period until it decreased in 2012 (26,494) and 2013 (21,388). The mean age was 65.5 yrs., median prostate specific antigen (PSA) was 5.9 ng/ml, mean body mass index was 32.2 kg/m2. The 30-day hospitalization rate after a prostate biopsy was 2.43%. Multivariable logistic regression revealed a significant increased risk of admission following prostate biopsy with increasing age (OR 1.02, 95% CI 1.01-1.02) and African American race (OR 1.20, 95 %CI 1.13-1.28). CONCLUSIONS The risk of hospitalization within 30 days of prostate biopsy was 2.4%. There was an increased risk of admission following prostate biopsy with increasing age and African American race. © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 193Issue 4SApril 2015Page: e149 Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.MetricsAuthor Information Mark Garzotto More articles by this author James Edwards More articles by this author Michael Conlin More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...